These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24975222)

  • 1. Resveratrol reduces the hypoxia-induced resistance to doxorubicin in breast cancer cells.
    Mitani T; Ito Y; Harada N; Nakano Y; Inui H; Ashida H; Yamaji R
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(2):122-8. PubMed ID: 24975222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of carbonyl reductase 1 as a resveratrol-binding protein by affinity chromatography using 4'-amino-3,5-dihydroxy-trans-stilbene.
    Ito Y; Mitani T; Harada N; Isayama A; Tanimori S; Takenaka S; Nakano Y; Inui H; Yamaji R
    J Nutr Sci Vitaminol (Tokyo); 2013; 59(4):358-64. PubMed ID: 24064738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.
    Mitani T; Harada N; Tanimori S; Nakano Y; Inui H; Yamaji R
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(4):276-82. PubMed ID: 25297617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.
    Li Z; Zhu Q; Hu L; Chen H; Wu Z; Li D
    Cancer Sci; 2015 Aug; 106(8):1041-9. PubMed ID: 26079208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells.
    Tak E; Lee S; Lee J; Rashid MA; Kim YW; Park JH; Park WS; Shokat KM; Ha J; Kim SS
    J Hepatol; 2011 Feb; 54(2):328-39. PubMed ID: 21056497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
    Cao Z; Fang J; Xia C; Shi X; Jiang BH
    Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
    Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
    Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reversal of adriamycin resistance by digoxin in human breast cancer cell line MCF-7/adriamycin and its mechanism].
    Li BH; Yuan L; Shi RR; Wang JG
    Sheng Li Xue Bao; 2015 Dec; 67(6):611-7. PubMed ID: 26701637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein.
    Sun Y; Wang H; Liu M; Lin F; Hua J
    Mol Med Rep; 2015 Mar; 11(3):1975-81. PubMed ID: 25384583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.
    Duyndam MC; van Berkel MP; Dorsman JC; Rockx DA; Pinedo HM; Boven E
    Biochem Pharmacol; 2007 Jul; 74(2):191-201. PubMed ID: 17498666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
    Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
    Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
    Zhou H; Fu LX; Li L; Chen YY; Zhu HQ; Zhou JL; Lv MX; Gan RZ; Zhang XX; Liang G
    J Ethnopharmacol; 2020 Oct; 261():113118. PubMed ID: 32621953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol.
    Park SY; Jeong KJ; Lee J; Yoon DS; Choi WS; Kim YK; Han JW; Kim YM; Kim BK; Lee HY
    Cancer Lett; 2007 Dec; 258(1):63-9. PubMed ID: 17919812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.
    Díaz-Chávez J; Fonseca-Sánchez MA; Arechaga-Ocampo E; Flores-Pérez A; Palacios-Rodríguez Y; Domínguez-Gómez G; Marchat LA; Fuentes-Mera L; Mendoza-Hernández G; Gariglio P; López-Camarillo C
    PLoS One; 2013; 8(5):e64378. PubMed ID: 23724044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human recombinant FSH induces chemoresistance in human breast cancer cells via HIF-1α activation†.
    Bergandi L; Canosa S; Pittatore G; Silvagno F; Doublier S; Gennarelli G; Benedetto C; Revelli A
    Biol Reprod; 2019 Jun; 100(6):1521-1535. PubMed ID: 30939201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-Regulation of Carbonyl Reductase 1 Renders Development of Doxorubicin Resistance in Human Gastrointestinal Cancers.
    Matsunaga T; Kezuka C; Morikawa Y; Suzuki A; Endo S; Iguchi K; Miura T; Nishinaka T; Terada T; El-Kabbani O; Hara A; Ikari A
    Biol Pharm Bull; 2015; 38(9):1309-19. PubMed ID: 26328486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-glucan from Lentinus edodes inhibits breast cancer progression via the Nur77/HIF-1α axis.
    Zhang X; Li T; Liu S; Xu Y; Meng M; Li X; Lin Z; Wu Q; Xue Y; Pan Y; Alitongbieke G
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33245358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Inhibition of MCT4 Reduces 4-Hydroxytamoxifen Sensitivity by Increasing HIF-1α Protein Expression in ER-Positive MCF-7 Breast Cancer Cells.
    Nadai T; Narumi K; Furugen A; Saito Y; Iseki K; Kobayashi M
    Biol Pharm Bull; 2021; 44(9):1247-1253. PubMed ID: 34471053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-induced increases in A549/CDDP cell drug resistance are reversed by RNA interference of HIF-1α expression.
    Min L; Chen Q; He S; Liu S; Ma Y
    Mol Med Rep; 2012 Jan; 5(1):228-32. PubMed ID: 21964646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.